Stay updated with the latest news and articles about Sun Pharma.
UBS has initiated sell ratings on key Indian pharmaceutical stocks including Zydus, Dr. Reddy's, Aurobindo, and Lupin, citing overestimated core margins and slow growth in their primary markets of India and the US.
Sales of Sun Pharma's formulations in India increased 5.1% to ₹3,560.4 crore. US formulation sales reached $471 million, a 12% YoY increase. More over one-third of the company's total consolidated sales came from sales in the US.
Top stocks to watch are Sun Pharma, Alembic Pharma, BEL, Crompton Greaves, and Campus Activewear, besides others.
Top stocks to watch today are HDFC Bank, HDFC, Can Fin Homes, Sun Pharma, and RVNL.
Today's stocks to watch: SAIL, Nykaa, Power Finance Corporation, Gujarat Gas, Castrol India, and Campus Activewear will release third-quarter fiscal year (Q3FY23) results.
Sun Pharma Q3 Results: The pharmaceutical company increased its net profit by 5.2% year on year to Rs 2,166 crore in the third quarter ended December 2022.
Stocks to Watch: Find out which businesses are creating news before the market opens.
The pharmaceutical company Sun Pharma reported an increase in consolidated revenue from operations of 13.8%.
Showing 45 of 52 articles